Carregant...
Immunotherapy in Gynecologic Cancers: Are We There Yet?
Immune-targeted therapies have demonstrated durable responses in many tumor types with limited treatment options and poor overall prognosis. This has led to enthusiasm for expanding such therapies to other tumor types including gynecologic malignancies. The use of immunotherapy in gynecologic malign...
Guardat en:
| Publicat a: | Curr Treat Options Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5936621/ https://ncbi.nlm.nih.gov/pubmed/28840453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-017-0504-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|